NCT01594879 Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT01580696 Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01562106 Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery Status COMPLETED Phase NA
NCT01560026 Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma Status UNKNOWN Phase N/A
NCT01550380 BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers Status WITHDRAWN Phase PHASE2
NCT01527396 Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer Status COMPLETED Phase N/A
NCT01526655 Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer Status COMPLETED Phase NA
NCT01523678 Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers Status COMPLETED Phase PHASE2
NCT01512810 Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer Status COMPLETED Phase PHASE2
NCT01482728 Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01467219 Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer Status COMPLETED Phase NA
NCT01461746 Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) Status UNKNOWN Phase N/A
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Status COMPLETED Phase N/A
NCT01401829 Psychosocial Benefits of Exercise in Endometrial Cancer Survivors Status TERMINATED Phase PHASE1
NCT01397877 GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer Status COMPLETED Phase PHASE2
NCT01379534 A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer Status COMPLETED Phase PHASE2